Resources Contact Us Home
Modified factor VIII

Image Number 8 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Contactless electrical connector for an induction sensor, and sensor including such a connector
Leg stretching device
Feature management of a communication device
Discovery, analysis, and visualization of dependencies
Topology discovery, control channel establishment, and datapath provisioning within an aggregation network with centralized control
Water purification using energy from a steam-hydrocarbon reforming process
Protection circuit, substrate for electro-optical device, electro-optical device, electrophoretic display device, electronic apparatus, and manufacturing method of electro-optical device
  Randomly Featured Patents
Systems and methods for the implementation of a peer-to-peer rule-based pull autonomous synchronization system
Multipart frac head with replaceable components
Scintillation scanner
Novel 3-acetoxymethyl-7-(iminoacetamido)-cephalosporanic acid derivatives
Frequency-modulation demodulator threshold extension device
Sliding key fob
RANK1, an ankyrin-repeat containing peptide from rice associated with disease resistance
Vertical field-effect semiconductor device with buried gate region
Color LCD with microcompensators
Ash tray equipped with disposable ash pocket